Insider Stock Trading History of Homcy Charles J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Homcy Charles J since year 2005. The trader's CIK number is 1192591. At the time of this reporting, Homcy Charles J is the Director of Portola Pharmaceuticals Inc . (stock ticker symbol PTLA). See this page for all insider trading activities at Portola Pharmaceuticals Inc .

Note that in the past HOMCY CHARLES J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Homcy Charles J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-23 PTLA Portola Pharmaceuticals Inc Option Ex 120,803 5.00 604,015
2017-06-23 PTLA Portola Pharmaceuticals Inc Sale 120,803 53.06 6,409,807
2017-06-01 GBT Global Blood Therapeutics, Inc. Sale 18,299 26.58 486,350
2017-06-02 GBT Global Blood Therapeutics, Inc. Sale 81,701 27.28 2,228,639
2017-03-15 PTLA Portola Pharmaceuticals Inc Option Ex 50,000 5.00 250,000
2017-03-15 PTLA Portola Pharmaceuticals Inc Sale 50,000 40.06 2,003,000
2017-03-01 PTLA Portola Pharmaceuticals Inc Option Ex 25,000 5.00 125,000
2017-03-01 PTLA Portola Pharmaceuticals Inc Sale 25,000 37.50 937,500
2015-09-18 PTLA Portola Pharmaceuticals Inc Sale 40,067 56.25 2,253,768
2015-09-18 PTLA Portola Pharmaceuticals Inc Option Ex 40,067 4.15 166,278
2015-07-13 PTLA Portola Pharmaceuticals Inc Option Ex 50,000 3.30 165,000
2015-07-13 PTLA Portola Pharmaceuticals Inc Sale 50,000 48.00 2,400,000
2015-06-29 PTLA Portola Pharmaceuticals Inc Option Ex 100,000 3.30 330,000
2015-06-29 PTLA Portola Pharmaceuticals Inc Sale 100,000 44.26 4,425,500
2015-02-23 PTLA Portola Pharmaceuticals Inc Sale 20,000 40.00 800,000
2015-02-23 PTLA Portola Pharmaceuticals Inc Option Ex 20,000 3.30 66,000
2015-02-17 PTLA Portola Pharmaceuticals Inc Option Ex 20,000 3.30 66,000
2015-02-17 PTLA Portola Pharmaceuticals Inc Sale 20,000 36.00 720,000
2015-02-13 PTLA Portola Pharmaceuticals Inc Option Ex 20,000 3.30 66,000
2015-02-13 PTLA Portola Pharmaceuticals Inc Sale 20,000 34.05 680,980
2015-01-28 PTLA Portola Pharmaceuticals Inc Option Ex 19,700 3.30 65,010
2015-01-28 PTLA Portola Pharmaceuticals Inc Sale 19,700 30.00 591,000
2015-01-27 PTLA Portola Pharmaceuticals Inc Option Ex 300 3.30 990
2015-01-27 PTLA Portola Pharmaceuticals Inc Sale 300 30.00 9,000
2013-10-22 PTLA Portola Pharmaceuticals Inc Sale 95,962 23.75 2,279,097
2007-12-11 MLNM Millennium Pharmaceuticals Inc Option Ex 59,238 6.49 384,454
2007-12-11 MLNM Millennium Pharmaceuticals Inc Sale 59,238 15.81 936,434
2007-09-19 MLNM Millennium Pharmaceuticals Inc Sale 40,000 10.68 427,200
2007-09-18 MLNM Millennium Pharmaceuticals Inc Sale 40,000 10.33 413,240
2007-09-17 MLNM Millennium Pharmaceuticals Inc Sale 10,000 9.76 97,630
2007-09-18 MLNM Millennium Pharmaceuticals Inc Option Ex 60,831 8.44 513,413
2007-09-05 MLNM Millennium Pharmaceuticals Inc Option Ex 30,000 8.44 253,199
2007-09-04 MLNM Millennium Pharmaceuticals Inc Sale 30,000 10.20 306,000
2007-02-16 MLNM Millennium Pharmaceuticals Inc Sale 27,774 11.24 312,179
2007-01-23 MLNM Millennium Pharmaceuticals Inc Option Ex 7,225 6.34 45,806
2007-01-24 MLNM Millennium Pharmaceuticals Inc Option Ex 2,394 6.34 15,177
2006-11-21 MLNM Millennium Pharmaceuticals Inc Option Ex 20,000 6.34 126,800
2006-11-21 MLNM Millennium Pharmaceuticals Inc Sale 20,000 11.44 228,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Homcy Charles J (Director of Portola Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.